CANTOR FITZGERALD, L. P.

Position in MRNA — Moderna, Inc.

CIK 1024896 NEW YORK, NY

Position in MRNA

as of Jun 30, 2026 · filed Aug 19, 2026 Compact

Position Value

$1,594,723

+$1,086,266 QoQ

Shares Held

22,772

+127.5% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#244

of 772 holders

Holding Since

Jun 2022

12 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

CANTOR FITZGERALD, L. P. holds $32,286,928 across 25 Biotechnology names. MRNA ranks #5 (4.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IMCR	Immunocore Holdings plc	340,100	$10,798,175
2	RNA	Atrium Therapeutics, Inc.	256,917	$3,455,533
3	INSM	INSMED Inc	25,000	$2,665,500
4	CABA	Cabaletta Bio, Inc.	800,001	$2,488,003
5	MRNA	Moderna, Inc. This page	22,772	$1,594,723
6	COGT	Cogent Biosciences, Inc.	35,000	$1,354,500
7	PTHS	Pelthos Therapeutics Inc.	38,123	$1,077,355
8	ACHV	Achieve Life Sciences, Inc.	121,631	$794,250

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,594,723	22,772	+127.5%	Shares	Defined	2026-08-19
2026-03-31	$508,457	10,009	-83.1%	Shares	Defined	2026-05-15
2025-09-30	$1,531,305	59,284	-0.5%	Shares	Defined	2026-02-17
2025-06-30	$1,644,088	59,590	-36.7%	Shares	Defined	2025-08-14
2025-03-31	$2,668,755	94,136	+455.0%	Shares	Defined	2025-05-15
2024-12-31	$705,238	16,961	-32.2%	Shares	Defined	2025-02-14
2024-06-30	$2,968,750	25,000	+12400.0%	Shares	Defined	2024-08-14
2023-12-31	$19,890	200	-95.9%	Shares	Defined	2024-02-14
2023-03-31	$743,327	4,840	-39.9%	Shares	Defined	2023-05-15
2022-12-31	$1,446,839	8,055	-72.1%	Shares	Defined	2023-02-14
2022-09-30	$3,407,965	28,820	-5.0%	Shares	Defined	2022-11-14
2022-06-30	$4,335,783	30,352	—	Shares	Defined	2022-08-15
No filing history on record for this holder in this stock.